The groundbreaking rise of copyright’s flagship product presented a significant prospect for shareholders , but its exclusivity has expired , creating a challenging landscape. Alternative versions have flooded the market , eroding revenues and putting a strain on profit percentages . While established pharmaceutical companies hold a presence in … Read More